West Pharmaceutical Services, Inc. (BVMF:W2ST34)

BVMF:W2ST34 Ratios and Metrics

Market cap in millions BRL. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Nov 6, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	109,122	146,722	126,418	92,112	193,584	108,768
Market Cap Growth	-14.08%	16.06%	37.24%	-52.42%	77.98%	143.27%
Enterprise Value	107,360	145,590	123,547	89,843	191,509	107,782
Last Close Price	40.74	56.10	48.87	37.20	74.38	-
PE Ratio	41.64	48.15	43.91	29.74	52.50	60.50
PS Ratio	6.78	8.20	8.83	6.04	12.27	9.76
PB Ratio	6.71	8.84	9.04	6.49	14.88	11.29
P/TBV Ratio	6.98	9.25	9.45	6.81	15.78	12.23
P/FCF Ratio	54.01	85.83	62.86	39.65	105.09	70.26
P/OCF Ratio	29.51	36.31	33.55	24.07	59.49	44.33
EV/Sales Ratio	6.57	8.14	8.63	5.89	12.14	9.67
EV/EBITDA Ratio	23.22	31.43	30.19	19.22	38.58	39.03
EV/EBIT Ratio	30.57	39.66	36.05	22.25	44.72	49.11
EV/FCF Ratio	53.14	85.17	61.43	38.68	103.97	69.62
Debt / Equity Ratio	0.10	0.11	0.11	0.12	0.14	0.18
Debt / EBITDA Ratio	0.36	0.39	0.35	0.35	0.36	0.60
Debt / FCF Ratio	0.80	1.11	0.75	0.72	0.98	1.11
Asset Turnover	0.78	0.77	0.79	0.83	0.93	0.84
Inventory Turnover	4.63	4.67	4.28	4.41	4.73	4.95
Quick Ratio	2.02	1.93	2.07	2.73	2.13	1.99
Current Ratio	2.87	2.80	2.88	3.70	2.93	2.73
Return on Equity (ROE)	16.95%	17.71%	21.32%	23.34%	31.59%	20.20%
Return on Assets (ROA)	10.22%	9.93%	11.86%	13.78%	15.73%	10.29%
Return on Capital (ROIC)	12.40%	12.01%	14.25%	16.86%	19.82%	12.92%
Return on Capital Employed (ROCE)	18.30%	19.20%	22.40%	24.70%	28.30%	18.50%
Earnings Yield	2.40%	2.08%	2.28%	3.36%	1.91%	1.65%
FCF Yield	1.85%	1.17%	1.59%	2.52%	0.95%	1.42%
Dividend Yield	0.22%	8.93%	7.65%	10.38%	5.17%	-
Payout Ratio	12.34%	12.00%	9.61%	9.23%	7.72%	13.89%
Buyback Yield / Dilution	1.55%	2.13%	0.66%	0.66%	-0.66%	-0.53%
Total Shareholder Return	1.78%	11.05%	8.31%	11.03%	4.51%	-0.53%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.